1. Home
  2. PLRX vs BAND Comparison

PLRX vs BAND Comparison

Compare PLRX & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • BAND
  • Stock Information
  • Founded
  • PLRX 2015
  • BAND 2000
  • Country
  • PLRX United States
  • BAND United States
  • Employees
  • PLRX N/A
  • BAND N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • PLRX Health Care
  • BAND Technology
  • Exchange
  • PLRX Nasdaq
  • BAND Nasdaq
  • Market Cap
  • PLRX 682.2M
  • BAND 431.4M
  • IPO Year
  • PLRX 2020
  • BAND 2017
  • Fundamental
  • Price
  • PLRX $11.21
  • BAND $15.68
  • Analyst Decision
  • PLRX Strong Buy
  • BAND Buy
  • Analyst Count
  • PLRX 7
  • BAND 8
  • Target Price
  • PLRX $40.50
  • BAND $27.86
  • AVG Volume (30 Days)
  • PLRX 577.5K
  • BAND 239.7K
  • Earning Date
  • PLRX 02-26-2025
  • BAND 02-26-2025
  • Dividend Yield
  • PLRX N/A
  • BAND N/A
  • EPS Growth
  • PLRX N/A
  • BAND N/A
  • EPS
  • PLRX N/A
  • BAND N/A
  • Revenue
  • PLRX N/A
  • BAND $703,904,000.00
  • Revenue This Year
  • PLRX N/A
  • BAND $25.91
  • Revenue Next Year
  • PLRX N/A
  • BAND $3.05
  • P/E Ratio
  • PLRX N/A
  • BAND N/A
  • Revenue Growth
  • PLRX N/A
  • BAND 18.76
  • 52 Week Low
  • PLRX $10.22
  • BAND $11.90
  • 52 Week High
  • PLRX $18.92
  • BAND $25.02
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 37.19
  • BAND 32.68
  • Support Level
  • PLRX $11.02
  • BAND $15.43
  • Resistance Level
  • PLRX $12.70
  • BAND $16.20
  • Average True Range (ATR)
  • PLRX 0.80
  • BAND 0.62
  • MACD
  • PLRX -0.18
  • BAND -0.08
  • Stochastic Oscillator
  • PLRX 8.21
  • BAND 10.71

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to large as well as small and medium-sized business, customers and is generally derived from usage and service fees. Usage revenue includes voice communication (driven by inbound and outbound minutes and toll-free minutes) and messaging communication (driven by the number of messages) that traverse the platform and network. Service fees include the provision and management of phone numbers and emergency services access.

Share on Social Networks: